SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-19-000521
Filing Date
2019-02-14
Accepted
2019-02-14 07:53:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 arrowmark-rvnc123118.htm SC 13G 52371
  Complete submission text file 0001172661-19-000521.txt   53923
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 19600811
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

IRS No.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G